Tavros Therapeutics is a precision oncology platform company leading the new frontier of targeted therapies exploiting tumors’ genetic vulnerabilities. Tavros is also leveraging its proprietary platform and map of useful synthetic lethal relationships to build a highly innovative pipeline of category-defining small-molecule drug candidates. Based in Research Triangle Park, N.C., management is comprised of successful serial entrepreneurs with deep expertise in functional genomics, tumor genetics and drug discovery.

Biotechnology

Life Sciences

Tavros Therapeutics

Eoin McDonnell

Kris Wood

Zachary Carico

Demi F.

Nikki Heron

The Research Team at Tavros Therapeutics focuses on identifying and validating genetic targets for precision oncology therapies. Through rigorous experimentation and innovative methodologies, they analyze tumors' genetic vulnerabilities to develop small-molecule drug candidates. Their collaborative efforts contribute to advancing the company's pipeline and enhancing understanding of synthetic lethal interactions in cancer treatment.

Research Team

Leadership Team

Research Team

About

Team members

Other teams at Tavros Therapeutics

Leadership Team